Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)

NCT02397928 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Pleural Mesothelioma

Interventions

DEVICE: NovoTTF-100L device
DRUG: Pemetrexed
DRUG: Cisplatin or Carboplatin

Sponsor

NovoCure Ltd.